Sleep Disordered Breathing
Conditions
Brief summary
Sleep disordered breathing (SDB) is common in cardiovascular patients. Patients after cardiac surgery will be screened for SDB with the ApnoeLink device at the beginning of cardiac Rehabilitation and then after 3 weeks and 3 months.
Detailed description
Objective(s) of the project * Evaluate the prevalence of sleep apnea after cardiac surgery * Compare results interindividually (group A vs. group B) and intraindividually (longitudinal assessment after 3 months) Outcome(s) * Prevalence of sleep apnoe at day 1 and 20 of rehabilitation and 3 months after cardiac surgery * composite endpoint of events at 3 months (cardiovascular death, non-fatal myocardial infarction, non-fatal cardiac arrest, revascularisation procedure, new atrial fibrillation and stroke) * change in 6-minute walking test (6-MWT) * impact of heart surgery on sleep apnoe
Interventions
OTHERscreening
Screening for sleep disordered breathing with the ApnoeLink Air device
Sponsors
Zürcher RehaZentrum Wald
Study design
Observational model
CASE_CONTROL
Time perspective
PROSPECTIVE
Eligibility
Sex/Gender
ALL
Healthy volunteers
No
Inclusion criteria
* cardiac surgery or orthopedic surgery \<2 weeks
Exclusion criteria
* known SDB
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Change of SDB prevalence after cardiac surgery measured with ApnoeLink Air device | day 1, day 20, 3 months | • Prevalence of sleep apnoe at day 1 and 20 of rehabilitation and 3 months after cardiac surgery assessed with the ApnoeLink Air device (ResMed) |
Countries
Switzerland
Contacts
PRINCIPAL_INVESTIGATORMatthias Hermann, MD
Zürcher RehaZentrum Wald
Outcome results
None listed